Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.90, read 2026-10-22
Ethical passes the values gate
Price8.87 USD
Fair value7.81
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Markup9.18-3.4% to today Markdown gives way to Markup first Markup read since July
2026-08-22Read Markdown8.78+1.0% to today Markup gives way to Markdown with volume flow in agreement
2026-07-02Read Markup9.19-3.5% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
BlackBerry Limited holds its Markup at $8.87. Consolidating, no directional conviction, held for 36 days.
As held on the ledger · 2026-10-20
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 36 days
Price at the screen
$8.87
Valuation
68.23 trailing · 37.63 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.30
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
17.29%
Below 33%
Interest-bearing debt is just 17.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
6.84%
Below 33%
Cash held in interest-bearing accounts and securities is 6.8% of assets, under the one-third limit.
Pass
Receivables
34.59%
Below 49%
Money owed to the company is 34.6% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
BlackBerry clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-22. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BB's ethical verdict changes
Today BB passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-20 screen. The gold marker is the market price at the same screen. The price runs 11.9% above the base estimate.
Third-party analyst targets: 7 covering, consensus None. The average target sits +7% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-20 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
BlackBerry still priced like a growth story
BlackBerry keeps pitching its secure comms tools and QNX software to governments and big firms, yet the numbers do not back the valuation. At eight dollars ninety nine the shares sit fourteen percent above our fair value, with a forward multiple of thirty nine times earnings on just ten percent profit margins and eight percent return on equity.
Revenue is growing at twenty six percent, which looks decent on the surface, but the market is already handing the company a premium that does not match the modest returns or the hold rating from seven analysts whose median target sits only modestly higher.
High multiples on low returns leave little room for disappointment, and any slowdown in licensing or enterprise deals would hit the share price quickly. Ethical checks clear, yet the price leaves no margin of safety. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Canada and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BB trades on the NYSE (the company is based in Canada). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-18Markup$8.70-5.2%Entry 8
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5. Insiders have been net sellers over the past quarter.
2026-10-11Markup$9.18+0.0%Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5.
2026-10-02Markup · changed$9.18+4.6%Entry 6
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5.
2026-08-22Markdown · changed$8.78-2.3%Entry 5
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5.
2026-07-22Markup$8.99-2.2%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5.
2026-07-18Markup$9.19+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading overbought. Over the past year the shares are up 117%. Our forward projection puts the odds of a 10% gain over the next month near 41%. The street (7 analysts) rates it hold, with a mean price target of $5.
2026-07-03Markup$9.19+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$9.19Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.